Drawing for MEDTRACK

USPTO serial 85003935

MEDTRACK

Reviewed by CopyMark Law Group

Reg. 3873342Status 710
Filing date
Status date
Registration date
Nov 9, 2010
Examiner
BESCH, JAY C
Law office
TMEG LAW OFFICE 108

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with MEDTRACK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kathryn Starshak

Kathryn Starshak K&L Gates LLPP.O. Box 1135Chicago, IL 60690-1135UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Market research services; analysis of market research data, namely, market research data concerning biomedical companies, market research data concerning pharmaceutical launches, market research data concerning financial and competitive product information, market research data concerning biomedical industry merger and acquisitions, and market research data concerning pharmaceutical and biomedical research; providing an on-line computer database in the field of market research data concerning biomedical companies, market research data concerning pharmaceutical launches, market research data concerning financial and competitive product information, market research data concerning biomedical industry merger and acquisitions, and market research data concerning pharmaceutical and biomedical research; compilation of statistics, namely, compilation of statistical models for gauging the market impact concerning the launch of pharmaceuticals and biomedical products; providing business information, statistical information, and on-line computer databases concerning the launch of pharmaceuticals and biomedical products and economic forecasting, analysis and feasibility related thereto; database management in the fields of market research, business information, statistical information and economic feasibility, economic analysis, and economic forecasting relating to biomedical companies, pharmaceutical launches, financial and competitive product information, biomedical industry merger and acquisitions, and pharmaceutical and biomedical researchSECTION 8 - CANCELLED—
036Financial analysis and research services in the field of pharmaceutical and biomedical companies and pharmaceutical and biomedical stock prices; financial evaluations in the field of pharmaceutical and biomedical companies and pharmaceutical and biomedical stock prices; financial information services provided online from a computer database or the internet, namely, providing financial information in the field of pharmaceutical and biomedical companies and pharmaceutical and biomedical stock prices; financial research and information services in the field of pharmaceutical and biomedical companies and pharmaceutical and biomedical stock pricesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 11, 2021CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Nov 9, 2019REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Feb 20, 2019ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Sep 13, 2018CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 13, 2018COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 17, 2017NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jan 17, 2017C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jan 14, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 7, 2016E815TEAS SECTION 8 & 15 RECEIVED—
May 25, 2016ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 18, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 18, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 9, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 24, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 24, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 22, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 22, 2010ALIEASSIGNED TO LIE—
Jul 7, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 7, 2010XAECEXAMINER'S AMENDMENT ENTERED—
Jul 7, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 7, 2010GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 7, 2010CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 1, 2010DOCKASSIGNED TO EXAMINER—
Apr 7, 2010MPMKNOTICE OF PSEUDO MARK MAILED—
Apr 6, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 5, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance